(Updated - December 29, 2021 3:51 AM EST)

Jefferies analyst Dennis Ding assumes coverage on Arbutus Biopharma (NASDAQ: ABUS) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE